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Objective(s): We investigated the influence of genetic variation of the transforming growth-factor alpha 
(TGFA) locus on the relationship between smoking and oral clefts. 
Materials and Methods: In this study 105 Iranian infants with non-syndromic cleft lip/palate and 218 
controls with non-cleft birth defects were examined to test for associations among maternal 
exposures, genetic markers, and oral clefts. Maternal and parental smoking histories during pregnancy 
were obtained through questionnaire. DNA was extracted from newborn screening blood samples, and 
genotyping of the BamHI polymorphism in the TGFA gene was performed by polymerase chain 
reaction (PCR) and restriction fragment length polymorphism (RFLP) methods. 
A number of factors including gender of the newborns, type of oral cleft, consanguinity of the parents, 
as well as the mother’s age and education were evaluated as potential confounders and effect 
modifiers. 
Results: Maternal smoking, in the absence of paternal smoking, was associated with an increased risk 
for CL/P (OR = 19.2, 95% CI = [(6.2-59.5)])   and cleft palate only (OR =48.7, 95% CI = [(8-29.3)]). If 
both parents smoked, risks were generally greater (OR = 55.6, 95% CI = [12-20.25]). Analyses for the 
risk of clefting from maternal smoking, stratified by the presence or absence of the 
TGFA/BamH1variant, revealed that the risk of clefting among the infants with the TGFA/BamH1 
variant when their mothers smoked cigarettes was much greater than the infants who had non-smoker 
mothers (P=0.001, OR=10.4,95% CI=[3.2,33.6]). 
Conclusion:The results of this study indicate that first-trimester maternal smoking and infant TGFA 
locus mutations are both associated with nonsyndromic cleft lip and/or palate (CL/P). 
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Introduction 
Cleft lip and palate (CL/P)  is a common birth 
defect which its risk factors include genes, 
environment, and their interaction (1, 2), gender (3), 
geographic location (4), nationality (4), and 
nutritional (5) and periconceptional consumption of 
folic acid (6–10). It has also been reported that 
tobacco use (11), antiepileptic drugs, and possibly 
alcohol consumption (12, 13), as well as birth weight, 
increase the incidence rate of oral clefts in newborns. 
Several studies have also reported that racial/ethnic 
factors (14, 15) and consanguinity (16–19) have an 
effect on the incidence rate of oral clefts, but findings 
have been inconclusive. Smoking has attracted 
special attention because of its common exposure 
(20), and common environmental exposures could 
play a role in the CL/P etiology if they accompany 
with other etiologic factors (21–23). 
Genetic factors are thought to contribute to the 
development of this disorder, because the risk of 
recurrence of CL/P within a family is approximately 
28–40-fold greater for the general population (4, 24). 
Identification of the genes involved in the 
development of the human craniofacial region can be 
considered as a first step towards developing a 
better understanding of the diagnosis, prevention 
and treatment of developmental anomalies of this 
region (25). 
Studies of segregation analysis have been extended 
by using candidate genes and linkage disequilibrium 
(24, 25). The association detected between CL/P               
and specific alleles in the transforming growth-factor 
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alpha (TGFA) gene strongly supports TGFA as a major 
gene component in CL/P (26,27). Subsequent work 
demonstrated that during craniofacial development 
TGFA was presented at high levels in epithelial tissue 
of the medial edge of the palatal shelves at the time 
of shelf fusion (28). In palatal cultures, TGFA 
promotes synthesis of extracellular matrix and 
migration of mesenchymal cells to ensure the 
strength of the fused palate during seam disruption 
(26-27). 
The TGFA gene is located on chromosome 2p13 
11, contains six exons and spans 80 kb of genomic 
DNA. Three common polymorphisms of the TNFA 
gene (RsaI, and TaqI in intron 5 and BamHI in exon 
6) have been investigated with susceptibility to the 
CL/P. 
Studies of gene–environment interaction effects 
have become increasingly important for complex 
traits such as clefting, whose etiology probably 
involves both genes and environmental factors                     
(29, 30). The first reports about the interaction 
between maternal smoking and TGFA genotype in 
CLP etiology have been published within the last few 
years. A statistically significant interaction between 
maternal smoking and infant TGFA genotype for 
isolated cleft palate (CP) was found by Hwang et al 
(31). A meta-analysis of 24 case-control and cohort 
studies of the association between maternal smoking 
during pregnancy and offspring oral clefts identified 
statistically significant associations between 
maternal smoking and CL/P and between maternal 
smoking and cleft palate only (CPO) (32). Thus, we 
conducted a case series study of Iranian infants born 
with an orofacial cleft, to investigate whether 
mothers who smoked cigarettes or fathers who 
smoked had an increased risk for having offsprings 
with orofacial clefts. We also investigated the 
influence of genetic variation of the infant’s TGFA 
locus on the relation between maternal smoke 
exposures and clefting, to evaluate a possible gene–
environment interaction among Iranian infants. 
 
Materials and Methods 
Samples were recruited from Mofid Hospital in 
Tehran, Iran, in 2013–2015. The control group 
consisted of DNA samples from 218 Iranians, without 
clefting (102 males and 116 females) whose blood 
samples were available. The case group consisted of 
105 infants (65 males and 40 females) with 
nonsyndromic CL/P (76 cleft lip and palate and 29 
cleft lip only). A clinical examination to look for 
dysmorphic features (such as lip pits) was 
undertaken. Cases with evidence of other facial or 
skeletal malformations were excluded from the 
study. Ethical approval for the study was obtained 
from the Ethics Committee of the Dental Research 
Center, Shahid Beheshti University of Medical 
Sciences, Tehran, Iran. Informed consent was 
obtained from all parents. Maternal smoking 
information in/at first trimester was obtained. The 
questionnaire addressing the relevant clinical and 
demographic factors for each case and control 
subject was completed by both the pediatrician and a 
nurse during an interview with the parents. The 
questionnaire data included infant’s birth date and 
gender, type of oral cleft, consanguinity of the 
parents, paternal smoking, as well as the mother’s 
age at pregnancy, education, and smoking status. 
 
Cigarette smoke exposure 
In the questionnaire, to assess maternal smoking, 
women were asked for the number of cigarettes they 
smoked daily for the first-trimester maternal 
smoking. To assess paternal smoking, a woman was 
asked how many cigarettes per day her infant’s 
biological father had smoked from 3 months before 
through 3 months after the gestation. 
 
TGFA genotyping 
Genomic DNA was extracted from peripheral 
blood lymphocytes according to the method 
described by Hwang (33). 
SNP genotyping was performed using a 
polymerase chain reaction-restriction fragment 
length polymorphism (PCR-RFLP) assay. The 
Polymerase Chain Reaction (PCR) primer was 
designed based on the SNP flanking sequence 
described in the Ensembl genome browser. 
The BamH1 polymorphic site is located within 
exon VI, thus, for screening of the BamH1 variant in 
the TGFA gene, exon VI of the gene was amplified by 
PCR using standard conditions along with modified 
primers (Forward Primer:gcctggcttatttggggatt 3ʹ and 
Reverse Primer: 5ʹaaagggcaaggaaacacaggʹ3). DNA 
fragments were separated and visualized by 
electrophoresis using 8% polyacrylamide gels. After 
digestion with the restriction enzyme BamHI, the 
amplified product was completely digested with one 
restriction site, and two specific bands of 120 bp and 
54 bp were indicated in wild-type genotype. 
 
Statistical analyses 
Data were analyzed by SPSS 11.5 (SPSS Inc. 
Chicago, USA). Descriptive results are shown as 
number and frequency. The odds ratio along with its 
95% confidence interval was used to estimate the 
risk using logistic regression analysis. For each 
phenotypic case group, analyses were performed for 
maternal cigarette smoking, paternal smoking, and 
both parents’ smoking. Analyses were also 
performed for maternal cigarette smoking for each 
phenotypic group with or without the uncommon 
(A2) TGFA allele. Maternal age and education were 
considered as potential covariates. Analyses were 
performed controlling for the influence of maternal 
education (less than a high school graduate, high 
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Table 1. Multivariate analysis to assess the effect of study variables on congenital cleft lip and/or palate malformation in the case group 
(n= 105) and control group (n= 218) of a case-control study 
 
Study variables Case group 
(n=105) (%) 
Control group 
(n=218)(%) 
OR (CI 95%) P-value 
Age at pregnancy (years): 
>25 
25-35 
<35 
45.7 40.8 1 ref* 
51.4 49.5 3.3(0.3-2.9) 0.006 
2.9 9.6 17.5(1.04-7) 0.001 
Maternal education: 
Not a high school graduate 
High school graduate 
College graduate 
58.1 33.9 1 Ref* 
34.3 41.3 3.3(1.4-7.85) 0.006 
7.6 24.8 17.5(3.4-90.4) 0.001 
Male child 61.9 46.8 0.95( 0.43- 2.1) 0.892 
Familial marriage 43.8 6 18.3(2.4-89.4) 0.001 
Maternal smoking 41 5 14.7(5.4-75.4) 0.001 
Paternal smoking 23.8 31.2 NA 0.254 
 
*Reference group 
 
school graduate and college graduate), age (<25, 25–
35, >35 years), and infant’s sex. P-values less than 
0.05 were considered statistically significant. 
 
Results 
The 105 cases consisted of 76 with CL/P and 29 
with isolated CP. The association of the evaluated 
risk factors with the occurrence of the cleft lip 
and/or palate CL/P is depicted in Table 1. The mean 
maternal age at pregnancy in the case and control 
groups were 25.9 and 25.1 years, respectively. There 
was a significant association between maternal age 
and increased risk for oral clefts (OR=17.5, CI 95% 
[1.04-7], P=0.001). CL/P case mothers were more 
likely to have had male infants as compared with 
control mothers, but there was no significant 
association between infant gender and oral clefts 
(P=0.95). Consanguineous marriages in parents of 
infants with a CL/P were 43.8%, whereas this rate 
was 6% in the control group. There was a significant 
association between consanguineous marriages and 
an increased risk of oral clefts (OR = 18.3, CI 95% 
[2.4- 89.4], P= 0.001). CL/P case mothers were less 
likely either to have attended a college or graduated 
from a college (P=0.001). A total of 5% of mothers in 
the control group and 41% in the case group reported 
smoking before conceiving or during pregnancy. Case 
mothers reported smoking during the month before 
conception more frequently than did control mothers 
(41% vs. 5%). There was significant association 
between maternal smoking and increased risk for oral 
clefts (OR = 14.7, 95% CI = [5.4-75.4], P= 0.001), but 
there was no significant association between paternal 
smoking and oral clefts (P= 0.254). 
Table 2 shows risk estimates associated with 
maternal smoking in the absence or presence of 
paternal smoking and vice versa. Among nonsmoking 
women, we found no evidence of an increased risk for 
clefting from paternal smoking. In the case of paternal 
smoking, in the absence of maternal smoking, the odds 
ratios were 0.45 and 11.2 with 95% CIs [0.2, 1.05] and 
[3.1, 40.3] for CL/P and isolated CP, respectively. 
In contrast, maternal smoking, in the absence of 
paternal smoking, was associated with an increased 
risk for CL/P and CPO (OR = 19.2, 95% CI= [6.2, 
59.5]; OR = 48.7, 95% CI = [8-293]), respectively. If 
both parents smoked, however, risks were generally 
greater than if only the mother smoked (OR = 55.6, 
95% CI= [12-256]). 
 
 
 
Table 2. Risk estimates for maternal and paternal cigarette smoking by case groupings 
 
 
 
*Number of case mothers/fathers in a given category. Number in parentheses is the number of control mothers/fathers.**Reference group 
 Maternal no. of cigarettes 
smoked/day 
 Paternal no. of cigarettes 
smoked/ day 
0 1–19 
*N OR &95% CI P-value 
 
N* OR &95% CI P-value 
 
Isolated 
CL±P 
 (n= 76) 
0 38 ref**  20 19.2 (6.2-59.5) 0.021 
1–19 7 0.45 (0.2-1.05) 0.254 11 6 (2.2-16.6) 0.005 
Isolated CP 
 (n= 29) 
0 3 ref  4 48.7 (8- 293) 0.041 
1–19 14 11.2 (3.1-40.3) 0.031 8 55.6 (12-256) 0.023 
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Table 3. Risk estimates for maternal cigarette smoking from 1 month before through 3 months after the conception, by case groupings and 
TGFA genotypes 
 
*Number of case mothers/fathers in a given category. Number in parentheses, number of control mothers/fathers.**Reference group 
***P= 0.001 
 
The BamH1 TGFA polymorphism was genotyped 
for 76 CL/P cases, 29 isolated CP cases, and 218 
controls. Compared with controls, genotype logistic 
regression analysis showed BamH1 genotype was 
associated with increased CL/P susceptibility (P= 
0.001, OR = 3.4, 95% CI =1.6, 7.4). 
Our previous study showed that the BamHI AC 
genotype was significantly higher (P=0.016) in the 
patients (12.4%) than the control group (5.0%). The 
BamHI C allele was significantly higher (P=0.001; 
OR=3.4, 95% CI: 1.6-7.4) in the cases (8.0%) 
compared with the control group (2.5%) (34). 
Analyses for the risk of clefting from maternal 
smoking, stratified by the presence or absence of the 
BamH1 TGFA polymorphism, revealed that the risk of 
clefting among infants with the BamH1 TGFA 
polymorphism was much greater than for infants 
with the common allele when their mothers smoked 
cigarettes (Table 3). Thus, maternal first-trimester 
smoking and infant TGFA locus mutations are 
associated with isolated CP and that a synergistic 
effect of these two risk factors occurs (P= 0.001, OR = 
10.4, 95% CI =3.2, 33.6]). 
 
Discussion 
The results of this study suggest that maternal, 
and not paternal, smoking during early pregnancy is 
associated with a 14.6-fold increased risk for 
orofacial cleft defect in infants. 
Several studies have examined the effect of 
maternal smoking on the risk for oral clefts. Using a 
Swedish registry, Kallen (34) performed a large case-
control analysis with a total of 1,834 oral cleft cases 
and found a statistically significant association 
between maternal smoking and both CL/P (OR = 
1.64, 95% CI = [1.33 to 2.02]) and CP (OR = 1.42, 
95% CI = [1.06 to 1.90]). Wyszynski et al (32) 
performed a meta-analysis utilizing the results from 
11 published studies and found an overall OR of 1.29 
(95% CI = [1.18, 1.42]) for any oral cleft in children 
of women who smoked. Their attributable risk of 
11% suggests that smoking is a general risk factor 
for all oral clefts, either with isolated CL/P or with CP 
alone. The increased risk observed for maternal 
smoking is consistent with Kallen et al (34) and 
Wyszynski et al (32) and contrasts Saxen (35), Evans 
et al (36), Hemminki et al (37), and Shiono et al (38),  
 
which may be due to genetic differences in that 
population. 
A study in 2015 (39) evaluated the relationship 
between maternal passive smoking and nonsyndromic 
orofacial clefts, and compared the associations between 
passive and active smoking. Results of this systematic 
review showed that maternal passive smoking 
exposure results in a 1.5 fold increase in the risk of 
orofacial clefts, similar to the magnitude of risk 
reported for active smoking. But the results of our 
study suggest that maternal, and not paternal, smoking 
during early pregnancy is associated with a 14.6-fold 
increased risk for orofacial cleft, which may be due to 
differences in the distribution of cleft types, adjustment 
for covariates, broad geographic region, or study 
bias/quality. 
No previous study has examined the clefting risk to 
offspring from both parents’ smoking in the Iranian 
population. 
Our study showed that the risk of orofacial clefting 
is influenced by the interaction between genotype 
(TGFA) and maternal smoking. Also, there was a strong 
association between maternal smoking and a genetic 
variant of TGFA in the risk for clefting. Similar to our 
results, Hwang et al (31) showed that there was an 
increase in the number of infants with CP who carried 
the TGFATaq1 variant compared with controls with an 
isolated, non-cleft birth defect, and this difference was 
greatly increased among infants of mothers who 
smoked. The biological mechanisms of how maternal 
smoking and TGFA genotype interact in the etiology of 
oral clefts remain unknown, It is very likely that several 
genes are involved in the etiology of nonsyndromic oral 
clefts and that these may interact with one another or 
with environmental risk factors, such as maternal 
smoking. 
The teratogenic effects of smoking have been      
well documented. Cigarettes contain N-nitroso 
compounds and polycyclic aromatic hydrocarbons 
such as benzo (a) pyrene, some of which are known 
or suspected teratogens in laboratory animals (11, 
40, 41). 
The first reports about the interaction between 
maternal smoking and TGFA genotype in CL/P 
etiology have been published by Hwang et al (31); 
the study describes the association between CP, 
CL/P, and TGFA and shows there was an increase in 
the number of infants with CP who carried the 
 TGF-alpha(Bam H1) 
 Maternal no. of  cigarettes 
smoked/day 
AA AC+CC 
N* OR &95%  CI N* OR &95%  CI 
Isolated CL±P (n = 76) 0 42 ref** 3 2.6 (0.6-12.1) 
1-19 28 1.5 (0.9-2.8) 3 1.6 (0.4-6) 
Isolated CP (n = 29) 0 15 ref 2 4.8 (0.8-28.8) 
1-19 5 0.8 (0.28-2.3) 7 10.4 (3.2-33.6)*** 
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TGFATaq1 variant compared with controls with an 
isolated, noncleft birth defect, and this difference 
was greatly increased among infants of mothers who 
smoked. 
Epidemiologic evidence pointing to maternal 
smoking during pregnancy are strongly suggested to 
be involved in the pathogenesis of nonsyndromic 
orofacial clefts (22, 42, 43-63). Several mechanisms 
for the detrimental actions of tobacco use have been 
proposed. It has been postulated (20) that women 
who smoked during pregnancy had compromised 
uteroplacental blood flow that could result in poor 
fetal development. Carbon monoxide affects oxygen 
transfer to the placenta, and nicotine constricts the 
uterine wall resulting in hypoxia. Hypoxia has been 
shown experimentally to induce orofacial cleft 
defects (44, 45) as well as other malformations. 
Furthermore, cigarette smoking may decrease a 
pregnant woman’s serum folate and is probably 
associated with an increased risk for clefting (46, 47). 
Ebadifar et al in 2015 (48) evaluated the 
association of MTHFR gene single nucleotide 
polymorphisms (C677T and A1298C) and maternal 
supplementary folate intake with orofacial clefts in 
the Iranian population. They found that children 
carrying the 677TT variant of the MTHFR gene may 
have an increased risk of CL/P and  the risk 
associated with this allele was obviously higher 
when the mothers did not use folic acid, which 
supports the fact that folic acid may play a role in the 
etiology of CL/P(47). 
As mentioned earlier, TGFA is the most widely 
studied candidate gene associated with the risk for 
oral clefts since it was present at high levels in 
epithelial tissue of the medial edge of the palatal 
shelves at the time of shelf fusion (26). Thus, 
smoking may affect the expression of TGFA involved 
in palatogenesis (30–32). Hence, allelic variants in 
BamH1/TGFA demonstrated the influence of 
smoking on CL/P risk. Moreover, how the evidence 
relates to the observations made with the gene 
variant of TGFA is unknown but may prove 
informative to those investigating mechanisms 
underlying the relation between TGFA and lip and 
palate formation/closure. 
Based on this study, oral clefts are more common 
in males, and this result was not statistically 
significant indicating there is no association between 
gender and oral clefts. This result is similar to other 
studies in Pakistan (49), Scotland (50), and Ireland 
(51). 
According to our results, there was a significant 
association between maternal age and oral clefts, 
which was in accordance with studies done by 
Herkrath and coworkers (52) and is in contrast to a 
study by Jagomagi and colleagues (53),  Abramowic 
(54), and Fathololumi and colleagues (55). 
Based on our findings, consanguinity was 
significantly associated with an increase in the rate 
of oral clefts. This result is similar to other reports 
(53-55), but several studies in; Iran (48, 56), 
Pakistan (49), and South India (57) have reported a 
non-significant association between familial 
matrimony and orofacial clefts. 
We observed that there is a significant 
association between maternal education and the risk 
of oral clefts, and that CL/P case mothers had lower 
educational levels. Our finding is similar to a study in 
India by Reddy and colleagues (57) and is in contrast 
to a study by Lebby and colleagues (58). This 
difference in results could be related to differences in 
environmental exposure, racial and geographic 
differences (53–58). 
 
Conclusion 
To conclude, the demonstration of an interaction 
between maternal smoking and BamH1 variant may 
make it possible for risk counselors to identify couples 
for whom behavior modification may help substantially 
reduce oral cleft risk. As the genetic constitution is not 
modifiable, these findings emphasize the importance of 
preconception counseling of mothers-to-be on 
amendable lifestyle factors, such as smoking and 
dietary habits, in order to reduce the prevalence of 
CL/P in future generations. Thus, our data support the 
advice of cessation of smoking during pregnancy. The 
limitation of this study was the sample size. These data 
should be further investigated in larger studies and in 
other populations as well. It seems likely that future 
progress in the understanding of the etiologic basis for 
CL/P will come from such studies of gene–environment 
interaction.  
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